Move Free Joint Strenghtener Plus MSM 120 tablets: K
Schiff Move Free® Plus MSM combines Glucosamine and Chondroitin with Methylsulfonylmethane (MSM) for added joint health support.** Move Free® Plus MSM provides more MSM per serving than any other leading brand. MSM is a naturally occurring organic sulfur source. MSM’s supply of sulfur may be used in other biochemical reactions throughout the body. Glucosamine and Chondroitin help support cartilage and maintain structural integrity of joints and connective tissue.** Glucosamine helps provide the building blocks for joint fluid, cartilage, tendons, ligaments, membranes and blood vessels.** Chondroitin Sulfates protect the structural integrity of joints and blood vessels.** Primary Use: Joint Health.** Secondary Use: General Health and Well-Being.** Glucosamine is not only safe but an active supporter of proteoglycan synthesis (i.e., a producer of cartilage macromolecules consisting of a protein bound to a glucosaminoglycan). There is increasing evidence that Glucosamine does in fact relieve joint pain and inflammation for many arthritis sufferers, and that it may slow progression of the disease. Because of its ability to reduce and--in some cases--completely eliminate the pain of osteoarthritis, some physicians and researchers feel Glucosamine might offer similar benefits for people suffering from rheumatoid arthritis, ankylosing spondylitis, spinal disc degeneration, tendinitis, bursitis, and physical injuries to the joints. There is even speculation that it could play a preemptive role, eliminating the development of osteoarthritis. Glucosamine stimulates the production of glycosaminoglycans and proteoglycans, two essential building blocks of cartilage. This appears to 'jump start' the body’s own natural production of Glucosamine. Combining Glucosamine with chondroitin sulfate has been demonstrated to increase its effectiveness. Glucosamine has been used to treat osteoarthritis in Europe since the 1980s. Several recent scientific studies have supported its effectiveness, and its popularity in the U.S. is spreading quickly. In November 1999, a Belgian group of researchers presented a study to the American College of Rheumatology showing that glucosamine may slow the progression of osteoarthritis of the knee. At a recent symposium of the American Academy of Orthopaedic Surgeons, the official 'green light' was given to glucosamine as a valid therapeutic alternative when NSAIDs such as aspirin and ibuprofen are ineffective or contraindicated. Other clinicians at the symposium suggested that glucosamine could be recommended as first-line therapy in selected patients with osteoarthritis. Glucosamine, in either the sulfate, HCL, or acetylated forms, is so safe that it is a dietary supplement not even subject to FDA approval. As for chondroitin, a recent analysis of the combined results of seven randomized, controlled trials indicated that the supplement may reduce osteoarthritis symptoms and improve function by an average of some 5